Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu.

J Immunol 2004 Jul;173(1):394-401

BioLife Science, and Department of Pathophysiology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

Immunizations with the oncogenic protein Her-2/neu elicit Abs exerting diverse biological effects--depending on epitope specificity, tumor growth may be inhibited or enhanced. Trastuzumab (herceptin) is a growth-inhibitory humanized monoclonal anti-Her-2/neu Ab, currently used for passive immunotherapy in the treatment of breast cancer. However, Ab therapies are expensive and have to be repeatedly administered for long periods of time. In contrast, active immunizations produce ongoing immune responses. Therefore, the study aims to generate peptide mimics of the epitope recognized by trastuzumab for vaccine formulation, ensuring the subsequent induction of tumor growth inhibitory Abs. We used the phage display technique to generate epitope mimics, mimotopes, complementing the screening Ab trastuzumab. Five candidate mimotopes were isolated from a constrained 10 mer library. These peptides were specifically recognized by trastuzumab, and showed distinctive mimicry with Her-2/neu in two experimental setups. Subsequently, immunogenicity of a selected mimotope was examined in BALB/c mice. Immunizations with a synthetic mimotope conjugated to tetanus toxoid resulted in Abs recognizing Her-2/neu in a blotted cell lysate as well as on the SK-BR-3 cell surface. Analogous to trastuzumab, the induced Abs caused internalization of the receptor from the cell surface to endosomal vesicles. These results indicate that the selected mimotopes are suitable for formulation of a breast cancer vaccine because the resulting Abs show similar biological features as trastuzumab.

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.173.1.394DOI Listing
July 2004
10 Reads

Publication Analysis

Top Keywords

recognized trastuzumab
12
protein her-2/neu
8
tumor growth
8
breast cancer
8
cell surface
8
epitope recognized
8
oncogenic protein
8
peptide mimics
8
mimics epitope
8
trastuzumab
7
abs
5
isolated constrained
4
constrained mer
4
subsequently immunogenicity
4
candidate mimotopes
4
immunogenicity selected
4
trastuzumab candidate
4
mimotopes isolated
4
library peptides
4
distinctive mimicry
4

References

(Supplied by CrossRef)

Mol. Cell. Biol. 1986

Oncogene 1990

Oncology 2001

Biochim. Biophys. Acta 1994

J. Immunol. 1999

Cancer Res. 1998

Biochim. Biophys. Acta 1998

Cancer Res. 1993

Cancer Res. 1994

Similar Publications